3553 results for «2280»
3553 results
Rapid-fire - PVL after TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
This session of rapid-fire submitted cases focuses on PVL after TAVI. Explore complex cases such as acute haemolytic anaemia associated with paravalvular leak after TAV-in-TAV, haemolytic anaemia due to a small paravalvular leak, and others.
Tricuspid valve disease: diagnosis and classification
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Discover, in this comprehensive 3rd episode of PCR Imaging Valves Madrid 2024, the nuances of diagnosing and grading tricuspid valve disease, including insights into normal and abnormal function post-repair or replacement, the pivotal role of imaging in valve quantification and device selection, strategies for assessing right ventricular...
TAVI for patients with concomitant coronary artery disease - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...
Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm).
After a predilatation with a 20 mm...
The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management
17 Feb 2024 – From PCR Tokyo Valves 2024
This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...
Challenges in TEER for secondary mitral regurgitation
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...
Heart Team in action: managing complex cases together
17 Feb 2024 – From PCR Tokyo Valves 2024
In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments.
PCR Tokyo Valves 2024 Welcome Ceremony
17 Feb 2024 – From PCR Tokyo Valves 2024
After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...
TAVI and future coronary access - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...
Late-Breaking Trial session
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...
The role of WATCHMAN therapy in optimising results and future perspectives
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.
Rapid-fire - Bailout in TAVI
18 Feb 2024 – From PCR Tokyo Valves 2024
As TAVI is never risk-free, learn about bailout techniques to counter various complications through this series of rapid-fire case submissions. This session explores cases such as a transcatheter aortic valve distortion following cardiopulmonary resuscitation, acute transcatheter aortic valve migration into the left ventricle, and valve embolization.
TEER for primary mitral regurgitation
18 Feb 2024 – From PCR Tokyo Valves 2024
What are the current indications and future perspectives of using TEER for primary mitral regurgitation? Join this session if you want to gain insight into anatomical evaluation before TEER, learn the procedural strategy for complex primary mitral regurgitation, and explore the specific features of both MitraClip...
TAVI optimisation
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this series of slides to enhance your understanding of TAVI optimisation through selected studies for PCR Tokyo Valves 2024. Learn about the prognostic value of right ventricle dysfunction after TAVR, explore a risk model in dialysis patients following TAVR, and explore the impact of age...
Rapid-fire - Mitral TEER for complex situations
18 Feb 2024 – From PCR Tokyo Valves 2024
This series of rapid-fire submitted cases focuses on mitral TEER for complex situations. Learn about creative solutions to these situations such as clip inversion grasping, independent leaflet grasping with a CGA system, and more!
Mastering techniques from basic to complex - Complex scenarios
16 Feb 2024 – From PCR Tokyo Valves 2024
Learn how to deal with common complex scenarios that might occur during TAVI through this teaching session. Explore complex scenarios such as a balloon valve modification and fracture, valve embolisation, and coronary occlusion through these slides!
Comprehensive assessment of mitral valve disorders and treatment outcomes
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
This session offers a comprehensive exploration of mitral valve disorders, covering diagnosis and severity assessment from multiple perspectives. From morphology-based diagnosis to echocardiography and CMR assessments, gain insights into distinguishing between rheumatic and calcific mitral stenosis, evaluating outcomes post-TMVR and surgical repair, and assessing bioprosthetic and...
The 2024 top Japanese abstracts
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the most outstanding Japanese abstract submissions from PCR Tokyo Valves 2024, including a study on the effect of chronic kidney disease in clinical outcomes of Japanese patients treated with MitraClip system, and insight into the deformation of transcatheter heart valves with mitral valve-in-valve.
TAVI essentials: anatomical factors, prosthesis selection, and complication management
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
Discover a comprehensive exploration of critical considerations in TAVI in this section. From anatomical factors guiding the choice between TAVI and SAVR to strategies for selecting the optimal TAVI prosthesis for individual patients, each topic offers essential insights. Gain valuable insights into navigating TAVI for bicuspid...
Unraveling aortic valve complexities: grading challenges, intervention decisions, and advanced imaging techniques
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore the complexities of aortic valve disorders in this PCR Imaging Valves Madrid 2024 session, covering topics from grading challenges to intervention decisions in both asymptomatic and symptomatic patients, and learn more about advanced imaging techniques for quantifying aortic regurgitation severity and navigating treatment choices for...
